| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
4,653 |
4,307 |
$191K |
| 84443 |
Thyroid stimulating hormone (TSH) |
11,682 |
11,185 |
$181K |
| 80061 |
Lipid panel |
10,933 |
10,467 |
$137K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
4,924 |
4,534 |
$119K |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
16,359 |
15,316 |
$118K |
| 80053 |
Comprehensive metabolic panel |
11,619 |
11,019 |
$114K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
3,043 |
2,886 |
$84K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
7,503 |
7,158 |
$67K |
| 82274 |
|
3,595 |
3,436 |
$53K |
| 36415 |
Collection of venous blood by venipuncture |
19,439 |
17,767 |
$53K |
| 81000 |
|
13,305 |
12,600 |
$39K |
| 86328 |
|
1,352 |
1,231 |
$32K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
3,776 |
3,575 |
$25K |
| 84153 |
|
1,387 |
1,316 |
$23K |
| 86738 |
|
1,496 |
1,467 |
$19K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
352 |
339 |
$18K |
| 82043 |
|
3,012 |
2,873 |
$17K |
| 87276 |
|
1,308 |
1,271 |
$17K |
| 87275 |
|
1,307 |
1,270 |
$16K |
| 87088 |
|
2,179 |
2,071 |
$16K |
| 86701 |
|
1,682 |
1,608 |
$16K |
| 82570 |
|
3,103 |
2,955 |
$15K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
1,862 |
1,782 |
$15K |
| 82607 |
|
1,035 |
971 |
$15K |
| 84480 |
|
987 |
918 |
$13K |
| 84439 |
|
1,406 |
1,319 |
$13K |
| 84436 |
|
1,772 |
1,685 |
$11K |
| 80074 |
|
218 |
206 |
$10K |
| 85651 |
|
3,284 |
3,127 |
$10K |
| 86592 |
|
1,604 |
1,529 |
$6K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
181 |
167 |
$6K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
183 |
169 |
$6K |
| 85730 |
|
568 |
525 |
$3K |
| 85610 |
|
649 |
600 |
$2K |
| 84479 |
|
376 |
371 |
$2K |
| 86038 |
|
112 |
108 |
$1K |
| 85027 |
|
205 |
183 |
$1K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
84 |
42 |
$1K |
| 83970 |
|
25 |
25 |
$1K |
| 82950 |
|
204 |
193 |
$892.41 |
| 86696 |
|
34 |
33 |
$634.58 |
| 86803 |
|
39 |
35 |
$593.53 |
| 82947 |
|
151 |
146 |
$534.31 |
| 86710 |
|
35 |
35 |
$450.30 |
| 86140 |
|
92 |
78 |
$381.75 |
| 82465 |
|
89 |
89 |
$359.31 |
| 86695 |
|
22 |
21 |
$290.16 |
| 87490 |
|
13 |
12 |
$289.44 |
| 87273 |
|
21 |
20 |
$248.24 |
| 87274 |
|
21 |
20 |
$248.24 |
| 87186 |
|
30 |
12 |
$247.50 |
| 84478 |
|
44 |
44 |
$237.99 |
| 83001 |
|
12 |
12 |
$210.00 |
| 80050 |
General health panel |
17 |
17 |
$167.69 |
| 87177 |
|
18 |
13 |
$115.71 |
| 84550 |
|
12 |
12 |
$54.60 |
| 87811 |
Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) |
388 |
368 |
$0.08 |
| 99211 |
Office or other outpatient visit for the evaluation and management of an established patient, minimal severity |
539 |
504 |
$0.00 |